Linfomas
Chen, LY, Aleman, A, Larrayoz, M, Chiu, H, Zhao, JF, Van Oekelen, O, Kelly, G, Kim-Schulz, S, Lagana, A, Jagannath, S, Lozano, T, Lasarte, JJ, Chow, TT, Hamley, J, Baker, W, Ebert, BL, Oppermann, U, Amatangelo, M, Gandhi, AK, Hagner, PR, Martinez-Climent, JA, Gooding, S, Milne, TA, Parekh, S
"Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies".
Blood. 148(9): 1129 - 1142. 2026. [doi:10.1182/blood.2025030891]
Panizo-Inogés, M, Marcos-Jubilar, M, González-Porras, JR, Puerta-Vazquez, C, Fernández-Arias, C, Rodríguez-Otero, P, Alfonso-Pierola, A, Villar, S, Canales, MA, Orbe, J, Páramo, JA, Prósper, F, Lecumberri, R
"Haemostatic changes during CART cell therapy and risk of complications (vol 75, 130, 2026)".
Cancer Immunol. Immunother.. 75(9): 215. 2026. [doi:10.1007/s00262-026-04425-9]
Pérez-Aguilera, M, Pedrosa, L, Gómez, S, Salazar-Ortego, S, Fernández-Miranda, I, Muñoz-Viana, R, Martín-Acosta, P, Martín-Lunas, BL, Jimeno, R, Yanguas-Casás, N, Horcajo, B, Roncador, G, Martínez-Climent, JA, Ortega-Molina, A, Sánchez-Beato, M
"Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B-Cell Lymphoma Cell Lines".
Hematol. Oncol.. 44(5): e70228. 2026. [doi:10.1002/hon.70228]
Corral, LL, Canales, MA, García-Sancho, AM, Serrano, JD, Díez, B, Sancho, SII, de Cerio, ALD, Rodríguez-Madoz, JR, Yañez, RM, Grande, C, Martín-López, AA, Pérez-López, E, López-Parra, M, Gutiérrez, NC, Villarón, EM, Navarro-Bailón, A, Espuch, JG, Cornago, J, Musseti, A, López-Franco, E, Pérez-Simón, JA, Bueren, J, Sánchez-Guijo, F, Prósper, F
"Phase I/IIA multicenter trial of non-viral sleeping beauty transposon-engineered CD19 CAR-T cells (TranspoCART19) in relapsed/refractory B-cell lymphomas: results from dose levels 1 and 2".
Bone Marrow Transplant.. 61: 39 - 41. 2026.
Gonzalez, C, Garces, JJ, Gracia, H, Guerrero, C, D'Agostino, M, Medina-Herrera, A, Nuvolone, M, Puig, N, Cedena, MT, Lasa, M, Alignani, D, Lopez, A, Sarvide, S, Aguirre-Ruiz, P, Lamo-Espinosa, JM, Prosper, F, Rodriguez-Otero, P, Martinez-Climent, JA, Lattarulo, F, Nevone, A, Massa, M, Palladini, G, Bertuglia, G, Gay, F, Rosiñol, L, García-Sanz, R, Martinez-Lopez, J, Mateos, MV, Lahuerta, JJ, Bladé, J, San-Miguel, JF, Paiva, B
"Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers".
Blood Cancer Discov.. 7(4): 558 - 571. 2026. [doi:10.1158/2643-3230.BCD-25-0102]
Cenzano, I, Cocera, M, Larrayoz, M, Campos-Dopazo, L, Sanz, S, Bantan, A, Vilas-Zornoza, A, San-Martin, P, Aguirre-Ruiz, P, Alignani, D, Lopez, A, Gonzalez, IS, Ruiz, J, Ripalda-Cemborain, P, Abengozar-Muela, M, Muiños-López, E, Lagani, V, Tegner, J, Hernáez, M, Agirre, X, Ebert, B, Paiva, B, Rodriguez-Otero, P, Tamariz-Amador, LE, San-Miguel, J, Saez, B, Martinez-Climent, JA, Calvo, IA, Gomez-Cabrero, D, Prosper, F
"Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response".
Nat. Commun.. 17(1): 7893. 2026. [doi:10.1038/s41467-026-74389-y]
Hutchings, M, Zelenetz, AD, Christensen, JH, Hernandez, AC, Assouline, SE, Castillo, LEM, Kothari, S, Modi, D, Albendea, MAC, Cubillas, D, Garcia-Sancho, AM, Diefenbach, CS, Kuruvilla, J, Caimi, PF, Patel, K, Landrette, S, Zhi, X, Zhang, YY, Meier, R, Matasar, M
"Phase 1 study of ARV-393, a PROTAC BCL6 degrader, as monotherapy in patients with advanced non-Hodgkin lymphoma (NHL) or combined with glofitamab in patients with diffuse large B-cell lymphoma (DLBCL).".
J. Clin. Oncol.. 44(16_SUPPL): 7103 - 7103. 2026. [doi:10.1200/JCO.2026.44.16_suppl.TPS7103]
Celay, J, Recalde, M, Revuelta, MV, Larrayoz, M, Vicente, C, Lozano, T, Gil, C, Chapman, JR, Garcia-Lacarte, M, Gonzalez, C, Ariceta, B, Rodriguez, S, Lasa, M, Garcia-Barchino, MJ, Fresquet, V, Jimenez, M, Sanz, S, Du, MQ, Roncador, G, Vega, Z, Sacco, A, Roccaro, A, Knittel, G, Reinhardt, HC, Piazza, R, Herter, S, Goodhew, R, Caron, J, Roos-Weil, D, Miguel, JS, Canales, M, Hodson, DJ, Lossos, IS, Lasarte, JJ, Roa, S, Prosper, F, Paiva, B, Cerchietti, L, Martinez-Climent, JA
"Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas".
Mol. Cancer. 25(1): 201. 2026. [doi:10.1186/s12943-026-02646-1]
Hutchings, M, Zelenetz, A, Christensen, JH, Hernandez, AC, Assouline, S, Castillo, LEM, Kothari, S, Modi, D, Albendea, MAC, Cubillas, D, Garcia-Sancho, AM, Diefenbach, CM, Kuruvilla, J, Caimi, PF, Patel, K, Landrette, S, Zhi, ER, Zhang, YY, Meier, R, Matasar, MJ
"Phase 1 study of ARV-393, a PROTAC BCL6 degrader, as monotherapy in patients with advanced non-Hodgkin lymphoma (NHL) or combined with glofitamab in patients with diffuse large B-cell lymphoma (DLBCL)".
Cancer Res.. 86(8): CT268. 2026. [doi:10.1158/1538-7445.AM2026-CT268]
Huerga-Domínguez, S, Ariceta, B, Aguirre-Ruiz, P, San Martín-Uriz, P, Sarvide, S, López-Janeiro, A, Alignani, D, López, A, Ezponda, T, Figueroa, R, Grande, C, Alfonso, A, Pena, E, Browne, S, Robledano, R, Vilas-Zornoza, A, Roa, S, Martínez-Climent, JA, Prósper, F, Canales, M
"Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas".
Cancers. 18(7): 1122. 2026. [doi:10.3390/cancers18071122]
|